I am aware that in the UK the NHS suggests a threshold for biopsy of 4.0ng/ml, yet the IMPACT study is referring patients for biopsy if they have a PSA level of 3.0ng/ml. Why?
Related Questions
- I am aware that in the UK the NHS suggests a threshold for biopsy of 4.0ng/ml, yet the IMPACT study is referring patients for biopsy if they have a PSA level of 3.0ng/ml. Why?
- What, if any, is the impact of NHS Links upon global health education in the UK?
- What key policy decisions need to be made during an impact fee study?